Skip to main content
. 2011 Dec;23(4):288–294. doi: 10.1007/s11670-011-0288-8

Table 7. Association between TUBB3 and response to different chemotherapy regimen.

Therapy RR% P OS (month) P PFS (month) P
TUBB3≤2 Paclitaxel 11/18(61.1%) 7.9 13.8
   Ciplatin 5/16(31.3%) 0.196 2.9 0.196 9.2 0.324
TUBB3>2 Paclitaxel 6/18(33.3%) 3.2 6.6
   Cisplatin 2/5(40%) 1.0 6.3 0.509 0.469